Skip to main content
. Author manuscript; available in PMC: 2021 Feb 1.
Published in final edited form as: Cancer Lett. 2019 Nov 22;470:170–180. doi: 10.1016/j.canlet.2019.11.025

Fig. 7 – Drug-treated cultured GL261 cells can vaccinate against live GL261 tumor rechallenge in vivo.

Fig. 7 –

(A) Anti-tumor vaccine experimental design. (B) 4HC or doxorubicin (Dox)-treated GL261 cells were inoculated into untreated mice. Control mice received an equivalent volume of PBS as a vehicle control. Shown is the time course of tumor appearance in mice implanted with untreated GL261 cells 1 week later (day 0). Data is based on n = 8-9 mice per group. Significance of the incidence of tumor-free mice was determined using the Kaplan-Meier method, with *p < 0.05, **p < 0.01, compared to the control vaccine group.